The DOI matches its Crossref record; 127 of the 127 references it cites were found in a registry or an index.
Treatment of Liver Cancer
Open accessAbstract
Primary liver cancer, mostly hepatocellular carcinoma, remains a difficult-to-treat cancer. Incidence of liver cancer varies geographically and parallels with the geographic prevalence of viral hepatitis. A number of staging systems have been developed, reflecting the heterogeneity of primary liver cancer, regional preferences, and regional variations in resectability or transplant eligibility. Multimodality treatments are available for this heterogeneous malignancy, and there are variations in the management recommendations for liver cancers across specialties and geographic regions. Novel treatment strategies have merged with the advance of new treatment modalities. This work focuses on reviewing the incidence, staging, and treatment of liver cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
(2017) · Springer eBooks · doi:10.1007/978-3-319-40618-3 · Cited by 17,242
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
Safety, activity, and immune correlates of anti–PD-1 antibody in cancer
Topalian, S. L., Hodi, F. S., Brahmer, J. R., Gettinger, S. N., Smith, D. C., McDermott, D. F., Powderly, J. D., Carvajal, R. D., Sosman, J. A., Atkins, M. B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200690 · Cited by 12,628
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
Hao (2015) · doi:10.1002/14651858 · Cited by 11,321
Mazzaferro, V., Regalia, E., Doci, R., Andreola, S., Pulvirenti, A., Bozzetti, F., Montalto, F., Ammatuna, M., Morabito, A., & Gennari, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341104 · Cited by 7,186
Egner, J. R. (2010) · JAMA · doi:10.1001/jama.2010.1525 · Cited by 5,997
A New Era of Systemic Therapy for Hepatocellular Carcinoma with Regorafenib and Lenvatinib
Kudo, M. (2017) · Liver Cancer · doi:10.1159/000462153 · Cited by 5,936
Cheng, A.-L., Kang, Y.-K., Chen, Z., Tsao, C.-J., Qin, S., Kim, J. S., Luo, R., Feng, J., Ye, S., Yang, T.-S., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70285-7 · Cited by 5,832
Sorafenib in Advanced Hepatocellular Carcinoma
정, 재. (2008) · Cited by 5,586
PD-1 and Its Ligands in Tolerance and Immunity
Keir, M. E., Butte, M. J., Freeman, G. J., & Sharpe, A. H. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090331 · Cited by 5,378
Acute Abdomen: A Rare Case of Ruptured Hepatocellular Carcinoma
Gloor, S., Jensen, K. O., Breitenstein, S., Binkert, C. A., Angst, E., & Hetzer, F. H. (2017) · Case Reports in Gastroenterology · doi:10.1159/000463378 · Cited by 5,370
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
European Association for the Study of the Liver, & European Organisation for Research and Treatment of Cancer (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.001 · Cited by 5,218
Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification
Llovet, J., Brú, C., & Bruix, J. (1999) · Seminars in Liver Disease · doi:10.1055/s-2007-1007122 · Cited by 3,805
Llovet, J. M., Real, M. I., Montaña, X., Planas, R., Coll, S., Aponte, J., Ayuso, C., Sala, M., Muchart, J., Solà, R., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08649-x · Cited by 3,494
Llovet, J. M., & Bruix, J. (2003) · Hepatology · doi:10.1053/jhep.2003.50047 · Cited by 3,029
The global health burden of infection‐associated cancers in the year 2002
Parkin, D. M. (2006) · International Journal of Cancer · doi:10.1002/ijc.21731 · Cited by 2,932
Global patterns of cancer incidence and mortality rates and trends
Jemal, A., Center, M. M., DeSantis, C., & Ward, E. M. (2010) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0437 · Cited by 2,778
Benson, A. B., Abrams, T. A., Ben-Josef, E., Bloomston, P. M., Botha, J. F., Clary, B. M., Covey, A., Curley, S. A., D'Angelica, M. I., Davila, R., et al. (2009) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2009.0027 · Cited by 2,268
Yao, F. Y., Ferrell, L., Bass, N. M., Watson, J. J., Bacchetti, P., Venook, A., Ascher, N. L., & Roberts, J. P. (2001) · Hepatology · doi:10.1053/jhep.2001.24563 · Cited by 2,262
Okuda, K., Ohtsuki, T., Obata, H., Tomimatsu, M., Okazaki, N., Hasegawa, H., Nakajima, Y., & Ohnishi, K. (1985) · Cancer · doi:10.1002/1097-0142(19850815)56:4<918::aid-cncr2820560437>3.0.co;2-e · Cited by 1,931
Altekruse, S. F., McGlynn, K. A., & Reichman, M. E. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.7753 · Cited by 1,694
Inhibitory B7-family molecules in the tumour microenvironment
Zou, W., & Chen, L. (2008) · Nature Reviews Immunology · doi:10.1038/nri2326 · Cited by 1,608
Lammer, J., Malagari, K., Vogl, T., Pilleul, F., Denys, A., Watkinson, A., Pitton, M., Sergent, G., Pfammatter, T., Terraz, S., et al. (2010) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-009-9711-7 · Cited by 1,557
Liu, L., Cao, Y., Chen, C., Zhang, X., McNabola, A., Wilkie, D., Wilhelm, S., Lynch, M., & Carter, C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1377 · Cited by 1,536
Hallmarks of Cancer: The Next Generation
Roizen, M. F. (2012) · Yearbook of Anesthesiology and Pain Management · doi:10.1016/j.yane.2012.02.046 · Cited by 1,501
Chen, M.-S., Li, J.-Q., Zheng, Y., Guo, R.-P., Liang, H.-H., Zhang, Y.-Q., Lin, X.-J., & Lau, W. Y. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000201480.65519.b8 · Cited by 1,432
Russell, S. J., Peng, K.-W., & Bell, J. C. (2012) · Nature Biotechnology · doi:10.1038/nbt.2287 · Cited by 1,428
A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients
(1998) · Hepatology · doi:10.1002/hep.510280322 · Cited by 1,238
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
(2012) · European Journal of Cancer · doi:10.1016/j.ejca.2011.12.021 · Cited by 1,096
Resection and Liver Transplantation for Hepatocellular Carcinoma
Llovet, J. M., Schwartz, M., & Mazzaferro, V. (2005) · Seminars in Liver Disease · doi:10.1055/s-2005-871198 · Cited by 879
Shiina, S., Teratani, T., Obi, S., Sato, S., Tateishi, R., Fujishima, T., Ishikawa, T., Koike, Y., Yoshida, H., Kawabe, T., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.009 · Cited by 877
Poon, R. T.-P., Fan, S. T., Lo, C. M., Liu, C. L., & Wong, J. (2002) · Annals of Surgery · doi:10.1097/00000658-200203000-00009 · Cited by 844
Self-citationWu, C.-Y., Chen, Y.-J., Ho, H. J., Hsu, Y.-C., Kuo, K. N., Wu, M.-S., & Lin, J.-T. (2012) · JAMA · doi:10.1001/2012.jama.11975 · Cited by 818
Gao, Q., Wang, X.-Y., Qiu, S.-J., Yamato, I., Sho, M., Nakajima, Y., Zhou, J., Li, B.-Z., Shi, Y.-H., Xiao, Y.-S., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1608 · Cited by 813
Takayasu, K., Arii, S., Ikai, I., Omata, M., Okita, K., Ichida, T., Matsuyama, Y., Nakanuma, Y., Kojiro, M., Makuuchi, M., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.05.021 · Cited by 810
Heo, J., Reid, T., Ruo, L., Breitbach, C. J., Rose, S., Bloomston, M., Cho, M., Lim, H. Y., Chung, H. C., Kim, C. W., et al. (2013) · Nature Medicine · doi:10.1038/nm.3089 · Cited by 779
Feng, K., Yan, J., Li, X., Xia, F., Ma, K., Wang, S., Bie, P., & Dong, J. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.05.007 · Cited by 767
Llovet, J. M., Vilana, R., Brú, C., Bianchi, L., Salmeron, J. M., Boix, L., Ganau, S., Sala, M., Pagès, M., Ayuso, C., et al. (2001) · Hepatology · doi:10.1053/jhep.2001.24233 · Cited by 759
Ishizawa, T., Hasegawa, K., Aoki, T., Takahashi, M., Inoue, Y., Sano, K., Imamura, H., Sugawara, Y., Kokudo, N., & Makuuchi, M. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.091 · Cited by 754
Kubota, K., Makuuchi, M., Kusaka, K., Kobayashi, T., Miki, K., Hasegawa, K., Harihara, Y., & Takayama, T. (1997) · Hepatology · doi:10.1002/hep.510260514 · Cited by 730
Kudo, M., Chung, H., & Osaki, Y. (2003) · Journal of Gastroenterology · doi:10.1007/s005350300038 · Cited by 700
Preoperative Portal Vein Embolization for Major Liver Resection: A Meta-Analysis
Abulkhir, A., Limongelli, P., Healey, A. J., Damrah, O., Tait, P., Jackson, J., Habib, N., & Jiao, L. R. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e31815f6e5b · Cited by 673
Prognosis of hepatocellular carcinoma: Comparison of 7 staging systems in an American cohort†
Marrero, J. A., Fontana, R. J., Barrat, A., Askari, F., Conjeevaram, H. S., Su, G. L., & Lok, A. S. (2005) · Hepatology · doi:10.1002/hep.20636 · Cited by 637
Decreased Incidence of Hepatocellular Carcinoma in Hepatitis B Vaccinees: A 20-Year Follow-up Study
Chang, M.-H., You, S.-L., Chen, C.-J., Liu, C.-J., Lee, C.-M., Lin, S.-M., Chu, H.-C., Wu, T.-C., Yang, S.-S., Kuo, H.-S., et al. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp288 · Cited by 635
Self-citationLin, S.-M., Lin, C.-J., Lin, C.-C., Hsu, C.-W., & Chen, Y.-C. (2005) · Gut · doi:10.1136/gut.2004.045203 · Cited by 592
Yeo, W., Mok, T. S., Zee, B., Leung, T. W. T., Lai, P. B. S., Lau, W. Y., Koh, J., Mo, F. K. F., Yu, S. C. H., Chan, A. T., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji315 · Cited by 590
Leung, T. W. T., Tang, A. M. Y., Zee, B., Lau, W. Y., Lai, P. B. S., Leung, K. L., Lau, J. T. F., Yu, S. C. H., & Johnson, P. J. (2002) · Cancer · doi:10.1002/cncr.10384 · Cited by 583
Raoul, J.-L., Sangro, B., Forner, A., Mazzaferro, V., Piscaglia, F., Bolondi, L., & Lencioni, R. (2011) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2010.07.006 · Cited by 537
Antagonist Antibodies to PD-1 and B7-H1 (PD-L1) in the Treatment of Advanced Human Cancer—Response
Sznol, M., & Chen, L. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2234 · Cited by 528
Park, B.-H., Hwang, T., Liu, T.-C., Sze, D. Y., Kim, J.-S., Kwon, H.-C., Oh, S. Y., Han, S.-Y., Yoon, J.-H., Hong, S.-H., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70107-4 · Cited by 521
(2000) · Hepatology · doi:10.1053/he.2000.5628 · Cited by 521
A new prognostic classification for predicting survival in patients with hepatocellular carcinoma
Chevret, S., Trinchet, J.-C., Mathieu, D., Rached, A. A., Beaugrand, M., & Chastang, C. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80173-1 · Cited by 512
Alifakioti, D., Daccord, C., Lachenal, Y., & Fitting, J.-W. (2014) · Respiration · doi:10.1159/000367814 · Cited by 495
Antagonist Antibodies to PD-1 and B7-H1 (PD-L1) in the Treatment of Advanced Human Cancer
Sznol, M., & Chen, L. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2063 · Cited by 488
Shi, F., Shi, M., Zeng, Z., Qi, R., Liu, Z., Zhang, J., Yang, Y., Tien, P., & Wang, F. (2011) · International Journal of Cancer · doi:10.1002/ijc.25397 · Cited by 464
Duffy, J. P., Vardanian, A., Benjamin, E., Watson, M., Farmer, D. G., Ghobrial, R. M., Lipshutz, G., Yersiz, H., Lu, D. S. K., Lassman, C., et al. (2007) · Annals of Surgery · doi:10.1097/sla.0b013e318148c704 · Cited by 445
Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma
Wu, J.-C., Huang, Y.-H., Chau, G.-Y., Su, C.-W., Lai, C.-R., Lee, P.-C., Huo, T.-I., Sheen, I.-J., Lee, S.-D., & Lui, W.-Y. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.07.009 · Cited by 435
Portal vein embolization: rationale, technique and future prospects
Abdalla, E. K., Hicks, M. E., & Vauthey, J. N. (2001) · Journal of British Surgery · doi:10.1046/j.1365-2168.2001.01658.x · Cited by 425
Prospective validation of the Barcelona Clinic Liver Cancer staging system
Cillo, U., Vitale, A., Grigoletto, F., Farinati, F., Brolese, A., Zanus, G., Neri, D., Boccagni, P., Srsen, N., D'Amico, F., et al. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.12.015 · Cited by 425
Poon, D., Anderson, B. O., Chen, L.-T., Tanaka, K., Lau, W. Y., Van Cutsem, E., Singh, H., Chow, W. C., Ooi, L. L., Chow, P., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70241-4 · Cited by 410
Targeted and armed oncolytic poxviruses: a novel multi-mechanistic therapeutic class for cancer
Kirn, D. H., & Thorne, S. H. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2545 · Cited by 402
Kudo, M., Chung, H., Haji, S., Osaki, Y., Oka, H., Seki, T., Kasugai, H., Sasaki, Y., & Matsunaga, T. (2004) · Hepatology · doi:10.1002/hep.20486 · Cited by 353
Advanced Hepatocellular Carcinoma: Which Staging Systems Best Predict Prognosis?
Huitzil-Melendez, F.-D., Capanu, M., O'Reilly, E. M., Duffy, A., Gansukh, B., Saltz, L. L., & Abou-Alfa, G. K. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.9895 · Cited by 335
Radioembolization for hepatocellular carcinoma
Sangro, B., Iñarrairaegui, M., & Bilbao, J. I. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.07.012 · Cited by 315
Yin, J., Li, N., Han, Y., Xue, J., Deng, Y., Shi, J., Guo, W., Zhang, H., Wang, H., Cheng, S., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.48.5896 · Cited by 307
Parato, K. A., Breitbach, C. J., Le Boeuf, F., Wang, J., Storbeck, C., Ilkow, C., Diallo, J.-S., Falls, T., Burns, J., Garcia, V., et al. (2012) · Molecular Therapy · doi:10.1038/mt.2011.276 · Cited by 305
Pawlik, T. M., Reyes, D. K., Cosgrove, D., Kamel, I. R., Bhagat, N., & Geschwind, J.-F. H. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.1021 · Cited by 304
Kim, J. H., Oh, J. Y., Park, B. H., Lee, D. E., Kim, J. S., Park, H. E., Roh, M. S., Je, J. E., Yoon, J. H., Thorne, S. H., et al. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.05.008 · Cited by 303
Lencioni, R., de Baere, T., Burrel, M., Caridi, J. G., Lammer, J., Malagari, K., Martin, R. C. G., O’Grady, E., Real, M. I., Vogl, T. J., et al. (2012) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-011-0287-7 · Cited by 287
Palmer, D. H., Midgley, R. S., Mirza, N., Torr, E. E., Ahmed, F., Steele, J. C., Steven, N. M., Kerr, D. J., Young, L. S., & Adams, D. H. (2009) · Hepatology · doi:10.1002/hep.22626 · Cited by 286
Wang, B., Xu, H., Gao, Z. Q., Ning, H. F., Sun, Y. Q., & Cao, G. W. (2008) · Acta Radiologica · doi:10.1080/02841850801958890 · Cited by 285
Trends in mortality from hepatocellular carcinoma in Europe, 1980‐2004†
Bosetti, C., Levi, F., Boffetta, P., Lucchini, F., Negri, E., & La Vecchia, C. (2008) · Hepatology · doi:10.1002/hep.22312 · Cited by 280
Nemunaitis, J., Tong, A. W., Nemunaitis, M., Senzer, N., Phadke, A. P., Bedell, C., Adams, N., Zhang, Y.-A., Maples, P. B., Chen, S., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2009.262 · Cited by 265
Telomerase-Specific Replication-Selective Virotherapy for Human Cancer
Kawashima, T., Kagawa, S., Kobayashi, N., Shirakiya, Y., Umeoka, T., Teraishi, F., Taki, M., Kyo, S., Tanaka, N., & Fujiwara, T. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1075-3 · Cited by 262
Altekruse, S. F., McGlynn, K. A., Dickie, L. A., & Kleiner, D. E. (2012) · Hepatology · doi:10.1002/hep.24710 · Cited by 262
Sorafenib in Advanced Hepatocellular Carcinoma
Harnois, D. M. (2009) · Yearbook of Medicine · doi:10.1016/s0084-3873(09)79537-9 · Cited by 257
Kubota, K. (1997) · Hepatology · doi:10.1053/jhep.1997.v26.pm0009362359 · Cited by 253
Fong, Z. V., & Tanabe, K. K. (2014) · Cancer · doi:10.1002/cncr.28730 · Cited by 250
Cheung, T. T., Poon, R. T. P., Yuen, W. K., Chok, K. S. H., Jenkins, C. R., Chan, S. C., Fan, S. T., & Lo, C. M. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e31827b947a · Cited by 236
Butterfield, L. H., Ribas, A., Dissette, V. B., Lee, Y., Yang, J. Q., De la Rocha, P., Duran, S. D., Hernandez, J., Seja, E., Potter, D. M., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2856 · Cited by 232
Indocyanine green clearance as a predictor of successful hepatic resection in cirrhotic patients
Hemming, A. W., Scudamore, C. H., Shackleton, C. R., Pudek, M., & Erb, S. R. (1992) · The American Journal of Surgery · doi:10.1016/0002-9610(92)90400-l · Cited by 228
Lencioni, R., Kudo, M., Ye, S. ‐., Bronowicki, J. ‐., Chen, X. ‐., Dagher, L., Furuse, J., Geschwind, J. F., Guevara, L. L., Papandreou, C., et al. (2014) · International Journal of Clinical Practice · doi:10.1111/ijcp.12352 · Cited by 223
Liu, T.-C., Hwang, T., Park, B.-H., Bell, J., & Kirn, D. H. (2008) · Molecular Therapy · doi:10.1038/mt.2008.143 · Cited by 189
Mizukoshi, E., Nakamoto, Y., Arai, K., Yamashita, T., Sakai, A., Sakai, Y., Kagaya, T., Yamashita, T., Honda, M., & Kaneko, S. (2011) · Hepatology · doi:10.1002/hep.24149 · Cited by 175
Burroughs, A. K., Hochhauser, D., & Meyer, T. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01508-6 · Cited by 159
Hwang, T.-H., Moon, A., Burke, J., Ribas, A., Stephenson, J., Breitbach, C. J., Daneshmand, M., De Silva, N., Parato, K., Diallo, J.-S., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.132 · Cited by 159
Tai, W.-T., Cheng, A.-L., Shiau, C.-W., Huang, H.-P., Huang, J.-W., Chen, P.-J., & Chen, K.-F. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.01.047 · Cited by 158
Self-citationVitale, A., Morales, R., Zanus, G., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70144-9 · Cited by 156
Breitenstein, S., Dimitroulis, D., Petrowsky, H., Puhan, M. A., Müllhaupt, B., & Clavien, P. (2009) · British journal of surgery · doi:10.1002/bjs.6731 · Cited by 151
Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma
Samuel, M., Chow, P. K. H., Shih‐Yen, E. C., Machin, D., & Soo, K. C. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001199.pub2 · Cited by 145
Torzilli, G., Donadon, M., Marconi, M., Palmisano, A., Fabbro, D. D., Spinelli, A., Botea, F., & Montorsi, M. (2008) · Archives of Surgery · doi:10.1001/archsurg.143.11.1082 · Cited by 144
Liver transplantation in patients with hepatocellular carcinoma across Milan criteria
Herrero, J. I., Sangro, B., Pardo, F., Quiroga, J. A., Iñarrairaegui, M., Rotellar, F., Montiel, C., Alegre, F., & Prìeto, J. (2008) · Liver Transplantation · doi:10.1002/lt.21368 · Cited by 140
Verslype, C., Cutsem, E. V., Dicato, M. A., Arber, N., Berlin, J. D., Cunningham, D., de Gramont, A., Díaz‐Rubio, E., Ducreux, M. P., Gruenberger, T., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp281 · Cited by 136
Chan, A. C. Y., Chan, S. C., Chok, K., Cheung, T. T., Chiu, D. W., Poon, R. T. P., Fan, S. T., & Lo, C. M. (2013) · Liver Transplantation · doi:10.1002/lt.23605 · Cited by 127
Potential of immunotherapy for hepatocellular carcinoma
Breous, E., & Thimme, R. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.10.013 · Cited by 127
Guglielmi, A., Ruzzenente, A., Pachera, S., Valdegamberi, A., Sandri, M. F., D’Onofrio, M., & Iacono, C. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01604.x · Cited by 120
Cho, Y. K., Chung, J. W., Kim, J. K., Ahn, Y. S., Kim, M. Y., Park, Y. O., Kim, W., & Byun, J. H. (2007) · Cancer · doi:10.1002/cncr.23185 · Cited by 115
Palavecino, M. E., Chun, Y. S., Madoff, D. C., et al. (2009) · Surgery · doi:10.1016/j.surg.2008.10.009 · Cited by 110
Zhao, Y., Wang, W. J., Guan, S., Li, H., Xu, R. C., Wu, J., Liu, J. S., Li, H. P., Bai, W., Yin, Z., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt072 · Cited by 108
Kim, M. K., Breitbach, C. J., Moon, A., Heo, J., Lee, Y. K., Cho, M., Lee, J. W., Kim, S.-G., Kang, D. H., Bell, J. C., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005361 · Cited by 101
Umemoto, Y., Okano, S., Matsumoto, Y., Nakagawara, H., Matono, R., Yoshiya, S., Yamashita, Y., Yoshizumi, T., Ikegami, T., Soejima, Y., et al. (2014) · Journal of Gastroenterology · doi:10.1007/s00535-014-0933-3 · Cited by 93
Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity
Chen, K., Tai, W., Hsu, C.-Y., Huang, J., Liu, C., Chen, P., Kim, I., & Shiau, C. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.07.023 · Cited by 89
Self-citationFeng, Q., Chi, Y., Liu, Y., Zhang, L., & Liu, Q. (2014) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1708-1 · Cited by 87
Cheng, A., Amarapurkar, D. N., Chao, Y., Chen, P., Geschwind, J.-F. H., Goh, K., Han, K., Kudo, M., Lee, H. C., Lee, R., et al. (2013) · Liver International · doi:10.1111/liv.12314 · Cited by 86
Self-citationIkai, I., Takayasu, K., Omata, M., Okita, K., Nakanuma, Y., Matsuyama, Y., Makuuchi, M., Kojiro, M., Ichida, T., Arii, S., et al. (2006) · Journal of Gastroenterology · doi:10.1007/s00535-006-1878-y · Cited by 86
Shu-hui, S. (2012) · Infectious Disease Information · Cited by 86
Huang, J., Hernandez‐Alejandro, R., Croome, K. P., Yan, L., Wu, H. M., Chen, Z., Prasoon, P., & Zeng, Y. (2010) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-010-1372-y · Cited by 80
Tai, W., Shiau, C., Chen, P., Chu, P., Huang, H., Liu, C., Huang, J., & Chen, K. (2013) · Hepatology · doi:10.1002/hep.26640 · Cited by 75
Self-citationLu, W., Dong, J., Huang, Z., Guo, D., Liu, Y., & Shi, S. J. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05527.x · Cited by 70
Bruix, J., Takayama, T., Mazzaferro, V., Chau, G., Yang, J., Kudo, M., Cai, J., Poon, R. T. P., Han, K., Tak, W. Y., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.32.15_suppl.4006 · Cited by 63
Liang, J., Ding, T., Guo, Z.-W., Yu, X.-J., Hu, Y.-Z., Zheng, L., & Xu, J. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.390 · Cited by 58
Immuno-histochemical detection of human telomerase reverse transcriptase in human liver tissues
Kawakami, Y., Kitamoto, M., Nakanishi, T., Yasui, W., 田原, 榮., Nakayama, J., Ishikawa, F., Tahara, H., Ide, T., & Kajiyama, G. (2000) · Oncogene · doi:10.1038/sj.onc.1203733 · Cited by 56
Effect of Transcatheter Hepatic Arterial Embolization on Angiogenesis in an Animal Model
Gupta, S. K., Kobayashi, S., Phongkitkarun, S., Broemeling, L. D., & Kan, Z. (2006) · Investigative Radiology · doi:10.1097/01.rli.0000209663.00629.8a · Cited by 54
Liver transplantation for malignancy: Current treatment strategies and future perspectives
Hackl, C. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i18.5331 · Cited by 46
Transarterial therapies for hepatocellular carcinoma
Sangro, B., D’Avola, D., Iñarrairaegui, M., & Prìeto, J. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.545346 · Cited by 38
Sorafenib derivatives induce apoptosis through inhibition of STAT3 independent of Raf
Chen, K., Tai, W., Huang, J., Hsu, C.-Y., Chen, W., Cheng, A., Chen, P., & Shiau, C. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.04.007 · Cited by 34
Self-citationBortezomib enhances radiation-induced apoptosis in solid tumors by inhibiting CIP2A
Huang, C., Wei, C., Chen, K., Chen, H.-J., Cheng, A., & Chen, K. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.11.005 · Cited by 31
Self-citationFurtado, R. V., Crawford, M., & Sandroussi, C. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-3511-2 · Cited by 24
Oncolytic Virotherapy as Emerging Immunotherapeutic Modality: Potential of Parvovirus H-1
Moehler, M. H., Goepfert, K., Heinrich, B., Breitbach, C. J., Delic, M., Galle, P. R., & Rommelaere, J. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00092 · Cited by 24
Oncolytic virotherapy for advanced liver tumours
Chang, J., Chen, P., Sze, D. Y., Reid, T. R., Bartlett, D. L., Kirn, D. H., & Liu, T. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00563.x · Cited by 19
Self-citationHeo, J., Chao, Y., Jonker, D. J., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.31.15_suppl.tps4161 · Cited by 10
Cited by
Hepatocellular Carcinoma: Molecular Mechanisms and Targeted Therapies
Alqahtani, A., Khan, Z., Alloghbi, A., S. Said Ahmed, T., Ashraf, M., & M. Hammouda, D. (2019) · Medicina · doi:10.3390/medicina55090526 · Cited by 265
Endoplasmic reticulum stress actively suppresses hepatic molecular identity in damaged liver
Dubois, V., Gheeraert, C., Vankrunkelsven, W., Dubois‐Chevalier, J., Dehondt, H., Bobowski‐Gerard, M., Vinod, M., Zummo, F. P., Güiza, F., Ploton, M., et al. (2020) · Molecular Systems Biology · doi:10.15252/msb.20199156 · Cited by 46
Metadata
- Authors
- Liu, C.-Y., Chen, K.-F., & Chen, P.-J.
- Venue
- Cold Spring Harbor Perspectives in Medicine
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2015-07-17
- Volume
- 5
- Issue
- 9
- Pages
- a021535
- ISSN
- 2157-1422 (ISSN-L)
- OpenAlex
- W2096108416
- Cited by
- 391
- References
- 127
- Type
- posted content
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.